ghk-cu peptide hair growth studies evidence clinical GHK Cu – Lily Lune GHK-Cu for Hair Loss: Clinical

L., Hannappel, E., & Kleinman, H

BPC-157 requires robust safety trials in humans first, then trials to determine the dose-response required to elicit meaningful therapeutic regenerative changes, followed by trials to establish the long term safety

Typical daily range: 200600 mcg once daily (gradual titration)

Expected timeline: Month 1-2: Inflammation management, symptomatic improvement Month 3-6: Potential slowing of degenerative markers, quality of life improvement Month 6-12: Assessment of structural changes, protocol optimization Ongoing: Maintenance protocols as needed, cycling strategies Complementary approaches: Anti-inflammatory nutrition